In the latest development, the European Commission has asked the EMA's human medicines committee, the CHMP, to take a look at ...
The European medicines regulator said on Friday it will review safety information for Eisai and Biogen's Leqembi, nearly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback